hnRNP M Activators
Heterogeneous nuclear ribonucleoprotein M (hnRNP M) is a crucial protein involved in RNA metabolism, particularly in pre-mRNA processing and alternative splicing regulation. Within the nucleus, hnRNP M modulates gene expression by interacting with nascent RNA transcripts, influencing their processing, localization, and stability. Its role extends to diverse cellular processes, including mRNA export, translation regulation, and RNA quality control. Additionally, hnRNP M has been implicated in cellular responses to stress and DNA damage, highlighting its multifaceted functions in maintaining cellular homeostasis.
Activation of hnRNP M involves intricate regulatory mechanisms that modulate its activity in RNA processing pathways. One such mechanism is post-translational modifications, including phosphorylation, methylation, and acetylation, which can alter hnRNP M's interaction with RNA and other protein partners. Another regulatory aspect involves its subcellular localization, as hnRNP M shuttles between the nucleus and cytoplasm in response to cellular signals. Furthermore, various signaling pathways, such as the MAPK and PI3K/AKT pathways, are known to influence hnRNP M activity through phosphorylation-dependent mechanisms. Moreover, the expression levels of hnRNP M can be regulated by transcription factors or microRNAs, affecting its availability and function in RNA processing. Overall, the activation of hnRNP M involves a complex interplay of post-translational modifications, subcellular localization, and signaling pathways, all of which contribute to its diverse roles in RNA metabolism and cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is an antibiotic that inhibits RNA synthesis. hnRNP M is involved in RNA metabolism, and the inhibition of RNA synthesis by actinomycin D can indirectly activate hnRNP M by affecting the abundance of RNA substrates and modulating RNA-protein interactions. The activation of hnRNP M by actinomycin D occurs as a consequence of its impact on RNA metabolism, enhancing hnRNP M function. | ||||||
NSC 319726 | 71555-25-4 | sc-477736 | 10 mg | $159.00 | ||
NSC 319726 is a small molecule activator of the tumor suppressor p53. hnRNP M interacts with p53, and the activation of p53 by NSC 319726 can indirectly activate hnRNP M by enhancing the hnRNP M/p53 interaction. The activation of hnRNP M through NSC 319726 occurs as a consequence of its impact on the hnRNP M/p53 interaction, promoting hnRNP M function. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $79.00 $321.00 $671.00 | 1 | |
Indirubin-3'-monoxime is a small molecule inhibitor of CDKs. hnRNP M is involved in cell cycle regulation, and the inhibition of CDKs by indirubin-3'-monoxime can indirectly activate hnRNP M by affecting the cell cycle dynamics in which hnRNP M participates. The activation of hnRNP M by indirubin-3'-monoxime occurs as a consequence of its impact on cell cycle progression, enhancing hnRNP M function. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an AMP-activated protein kinase (AMPK) activator. The activation of AMPK by AICAR can indirectly activate hnRNP M by influencing cellular processes regulated by AMPK. The activation of hnRNP M through AICAR occurs as a consequence of its impact on AMPK-mediated signaling pathways, enhancing hnRNP M function. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 Inhibitor IX (BIO) is a glycogen synthase kinase-3 (GSK-3) inhibitor. hnRNP M is known to be regulated by GSK-3, and the inhibition of GSK-3 by BIO can activate hnRNP M through interference with GSK-3-mediated phosphorylation events and subsequent regulatory mechanisms governing hnRNP M function. The activation of hnRNP M by BIO occurs as a consequence of its impact on GSK-3, promoting hnRNP M function. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is a protein tyrosine phosphatase (PTP) inhibitor. hnRNP M is known to be phosphorylated, and the inhibition of PTPs by sodium orthovanadate can indirectly activate hnRNP M by affecting its phosphorylation status. The activation of hnRNP M through sodium orthovanadate occurs as a consequence of its impact on hnRNP M phosphorylation, enhancing hnRNP M function. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Rottlerin is a natural product that modulates various cellular processes. Its impact on cellular signaling, including the protein kinase C (PKC) pathway, can indirectly influence hnRNP M, as hnRNP M is known to be regulated by PKC. The activation of hnRNP M by rottlerin occurs as a consequence of its impact on PKC-mediated signaling pathways, promoting hnRNP M function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is a natural product with anti-inflammatory properties. Its impact on cellular processes related to inflammation and proliferation can indirectly activate hnRNP M, as hnRNP M is involved in these processes. The activation of hnRNP M by curcumin occurs as a consequence of its broader effects on cellular function, promoting hnRNP M function in the context of inflammation and proliferation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. hnRNP M is known to be regulated by p38 MAPK, and the inhibition of p38 MAPK by SB203580 can activate hnRNP M through interference with p38 MAPK-mediated signaling pathways. The activation of hnRNP M by SB203580 occurs as a consequence of its impact on p38 MAPK, promoting hnRNP M function by preventing regulatory events associated with p38 MAPK signaling. | ||||||